QA: vTv Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001641489_2026_vTv_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001641489, vTv Therapeutics Inc

  xvar xval
0 AssetsCurrent 89,893,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 6,000
4 LiabilitiesCurrent 6,641,000
5 LiabilitiesNoncurrent 18,669,000
6 remainder_Liabilities 152,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,974,899
9 ResearchAndDevelopmentExpense 22,407,315
10 remainder_Expenses 37,049
11 remainder_Revenues 406,605
12 remainder_NetIncome 1,747,285
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 89,899,000
1 Liabilities 25,462,000
2 Expenses 37,419,263
3 Revenues 406,605
4 StockholdersEquity 64,437,000
5 NetIncome -35,265,373
6 ComprehensiveNetIncome -35,265,373
7 BaseVar 77,467,076
8 EconomicCapitalRatiobeforeLimitedLiability 1.82
9 EconomicCapitalRatio 2.90

Edgar->Model Mapping

Feature Distribution

Change over Time